IPREG-H-250
MRP: 120
Packaging: 1ml
Pack Type: injection
Composition:
Hydroxyprogesterone 250mg
Indication:
Premenstrual Syndrome, Premenstrual Syndrome, Conjugated Oestragens, Luteal Phase Deficiency.
Description:
Hydroxyprogesterone Caproate 250mg Injection is a synthetic progestogen used primarily to prevent preterm birth in pregnant women with a history of spontaneous preterm delivery. It mimics the action of natural progesterone by maintaining uterine quiescence and preventing contractions. This long-acting injectable formulation is administered intramuscularly, usually on a weekly basis during the second and third trimesters of pregnancy to support pregnancy continuation.
Tags:
- Reduces risk of spontaneous preterm birth
- Maintains uterine relaxation during pregnancy
- Supports pregnancy continuation in high-risk women
- Long-acting, weekly dosing improves compliance
- Well-tolerated with established safety profile in pregnancy
Usage Information
Dosage
Typical Dose: 250mg intramuscularly once a week Duration: From 16-20 weeks gestation up to 36 weeks or delivery Administered only under medical supervision Should not be self-administered
Side Effects
Injection site pain or swelling Headache or dizziness Nausea Mild fluid retention or weight gain Spotting or irregular bleeding Rare allergic reactions
Contraindications
Hypersensitivity to hydroxyprogesterone or components Undiagnosed vaginal bleeding during pregnancy History of thrombosis or thromboembolic disorders Liver dysfunction or tumors Known or suspected hormone-sensitive cancers
Availability
Hydroxyprogesterone 250mg injection Hydroxyprogesterone caproate uses Injection to prevent preterm labor Synthetic progesterone IM injection Pregnancy support hormone injection Preterm birth prevention injection Weekly progesterone injection during pregnancy